Stephen Horrigan

Stephen Horrigan

Company: Iterion Therapeutics

Job title: Chief Scientific Officer

Bio:

Join me at Wnt

Seminars:

Chair’s Closing Remarks & End of Summit 4:10 pm

Read more

day: Day Two

Chair’s Opening Remarks 9:00 am

Read more

day: Day Two

New Ways to Attack an Armadillo – Latest Approaches to Inhibit β-Catenin Signaling 8:30 am

• Sharing lessons learned on the various therapeutic mechanisms • Explore different modalities including Creb, siRNA, PROTAC and bispecifics – what is the best route to tame Wnt and β-catenin? • Debate the optimal approach of cellular target engagementRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.